Question 1

Is the lab testing trustworthy?

Accepted Answer

It is among the better setups we have examined, and that deserves saying before the criticism. Carmen's publishes a searchable table of certificates with columns for product name, laboratory, lot number and download — 32 PDFs in total when we counted. Crucially, it names the laboratories: Kaycha Labs appears in the table and Biocientific Lab appears in several filenames, both real testing houses rather than an unnamed 'independent third party'. Lot numbers are published alongside each entry, which is the mechanism that makes batch matching genuinely possible: you read the lot from your bottle and find the matching report. Several filenames carry 'Compliance' designations, and the file version stamps indicate reports from 2025 rather than an archive that stopped updating years ago. Coverage is broad, spanning softgels at 25mg and 50mg, oils at 1500mg, 3000mg and 6000mg, isolate tincture, Calm Gummies, Sleep Gummies, Deep Sleep Gummies, a CBN-CBD tincture, a kids' tincture and the THCV products. That is a real transparency infrastructure. What we would still do before buying: check that your specific lot appears, and read the panel scope rather than assuming — a certificate can be potency-only, and the panels that matter for an ingested product are heavy metals, pesticides, residual solvents and microbiology.

Question 2

What is the FIT THCV product claiming?

Accepted Answer

It claims to curb cravings and support blood sugar, and neither claim is supportable at the level it is made. Carmen's FIT THCV-CBD is $109.95 and combines THCV, CBD, vitamin D and K2. Its listed benefits are 'Supports Healthy Blood Sugar Levels', 'Helps Curb Cravings', 'Promotes Daily Wellness' and 'Natural, Balanced Formula'. Two of those are the reason this product appears in a review on a weight-management site. On cravings: THCV acts as an antagonist at the CB1 receptor, the mirror image of THC's appetite stimulation, so the mechanism is real pharmacology rather than invention. But the human evidence is thin. An early randomised study in type 2 diabetes found metabolic effects on glycaemic control without producing weight loss, and a small later study of THCV strips in around 44 participants over 90 days reported weight reduction at daily doses of roughly 8mg to 16mg. That is preliminary work, not a basis for a cravings claim. On blood sugar: 'supports healthy blood sugar levels' is the kind of phrasing that sits close to a diabetes claim, and anyone with diabetes or prediabetes should be treating that with their clinician rather than a $109.95 tincture. To Carmen's credit, a certificate titled 'Tincture-THCV-900mg' exists, so unlike another THCV product we reviewed this month the total is documented — but no per-serving figure appears on the product page, and per-serving is what determines whether you are anywhere near the studied doses.

Question 3

Is there a safety issue with THCV specifically?

Accepted Answer

There is a precedent worth knowing, and a genuine counterargument, and we want both on the record. The precedent is rimonabant, marketed as Acomplia. It was a CB1 inverse agonist licensed in Europe in 2006 for obesity, it worked on weight, and it was withdrawn in 2008 with the European regulator acting formally in January 2009 because of psychiatric adverse effects including depression, anxiety and suicidal ideation. It was never approved in the United States. That is the last time a medicine was brought to market to reduce appetite by acting on this receptor, and it is not a reassuring history. The counterargument is real: rimonabant was an inverse agonist rather than a plain blocker, researchers widely attribute its psychiatric effects to that inverse-agonist activity, and THCV is generally characterised as a neutral CB1 antagonist — which is precisely why a research line has pursued neutral antagonists in the hope of separating metabolic benefit from mood harm. So THCV is not rimonabant and it would be wrong to say it is. But nobody has run a trial large or long enough to establish that it avoids the problem. If you have any history of depression, anxiety or suicidal thoughts, this is a conversation to have with a clinician before buying an appetite product, not after. And if you are already on a GLP-1, you are paying for appetite suppression twice, with no data on the combination.

Question 4

What about the 'Pain Gummies' and the disease claims?

Accepted Answer

This is where we part company with the brand most clearly. The 50MG Pain Gummies Max Strength are described as follows: 'Whether you're managing chronic pain or occasional inflammation, 50 Mg Pain Gummies Max Strength deliver targeted relief you can rely on', with listed benefits including 'Targeted pain inflammation relief' and 'Natural anti-inflammatory properties'. Elsewhere, CBD capsules claim to help 'reduce stress and anxiety' and support 'relief from inflammation'. Chronic pain and anxiety are diagnosable medical conditions. A dietary supplement may make structure-function claims but may not claim to treat, mitigate or prevent a disease — doing so makes it an unapproved drug in the FDA's framework — and 'relief you can rely on' is an efficacy guarantee rather than a hedged claim. The brand name compounds it: 'Medicinals' tells you the product is medicine. To be fair, the full FDA disclaimer is present in the footer, stating the products are not intended to diagnose, treat, cure or prevent any disease — but that disclaimer directly contradicts the product names and the benefit lists above it, which is the same tension we have flagged at several other brands. The practical consequence for you: chronic pain deserves diagnosis and a management plan, because untreated causes get worse while you medicate the symptom with a gummy.

Question 5

How much THC is in these products?

Accepted Answer

More than the framing suggests, and it matters for two separate reasons. The 50MG Deep Sleep Gummies are described as 'an expertly balanced blend of 50 mg CBD, 50 mg CBN, and 5 mg THC'. Five milligrams of THC is an intoxicating dose — it is the standard low-to-moderate serving in legal cannabis markets, not a trace amount — and it is being sold as a sleep aid with the claim of 'balanced relaxation without grogginess'. The Pain Gummies also list THC among their actives alongside CBD, CBG, turmeric and ginger. The first reason this matters is straightforward: if you are subject to workplace drug testing, do not take these. Five milligrams is a real dose and THC metabolites are detectable. The second is regulatory. H.R. 5371, enacted 12 November 2025 and effective 12 November 2026, caps finished consumable products at 0.4 milligrams of total THC per innermost retail container. A single 5mg gummy is over twelve times that cap on its own, and a jar of them is far more. That provision is not about intoxication — it is a flat per-container limit — so the THC-containing gummies here have roughly three months of federal life left as we write. The pure CBD oils and capsules are in a different position, though full-spectrum products carry trace THC that can also breach the container cap.

Question 6

Should someone having chemotherapy use CBD?

Accepted Answer

Only with their oncologist's knowledge, and the reason is pharmacological rather than moral. Carmen's carries a message addressed to 'those facing the challenges of cancer and chemotherapy', and we want to characterise that fairly: the company was founded in 2018 by Juan Romero after his grandmother's cancer, and the brand carries her name. That reads as a sincere personal story rather than commercial targeting of a vulnerable group, and we are not going to pretend otherwise. The clinical caution stands regardless of motive. CBD inhibits several cytochrome P450 enzymes, notably CYP3A4 and CYP2C19, and a great many chemotherapy agents and supportive medicines are metabolised by those same enzymes. Inhibiting them can raise drug levels, and with cytotoxic drugs the margin between therapeutic and toxic is narrow — so an interaction is not a theoretical inconvenience, it can mean more toxicity from the same dose. There are also real questions about antioxidants and some treatment modalities, and about liver enzyme monitoring in someone already receiving hepatotoxic drugs. None of that means CBD is off the table: many oncology teams are entirely willing to discuss it, particularly for nausea or sleep. It means the conversation has to happen first. Tell your oncology team before starting anything, including a topical, and take the ingredient list with you.

Question 7

What does it cost?

Accepted Answer

Mid-to-high across the range. Checked on 8 August 2026: Calm Gummies 25mg $34.95, 30MG Pain Gummies $34.95, 30MG Sleep Gummies $34.95, CBD Capsules 25mg $34.95, 50MG Deep Sleep Gummies $44.95, 50MG Pain Gummies Max Strength $44.95, Better in a Balm $44.95, Apple Stem Cell Cream $44.95, Vitamin C Serum $49.95, CBD Oil 1500mg $64.95, CBD Capsules 50mg $64.95, CBD Oil 3000mg $99.95, Recovery Remedy Drops $109.95, Dream Drops $109.95, Carmen's FIT THCV-CBD $109.95, CBD Oil 6000mg and Isolate CBD Oil 6000mg both $129.95, and a Rest & Relaxation Bundle at $186.87. Free shipping applies over $60, and a subscribe-and-save offer gives 30% off the first three orders. Doing the per-milligram arithmetic that actually matters: the 6000mg oil at $129.95 works out around 2.2 cents per milligram of CBD, while the 1500mg at $64.95 is around 4.3 cents — so as with most CBD the larger bottle is roughly twice the value per milligram. That makes the higher strengths the sensible buy if you know CBD works for you, and the smaller gummies a reasonable way to find out first. Note the subscribe-and-save discount applies to the first three orders rather than continuously, so check what the fourth order costs.

Question 8

Is there any independent record of this company?

Accepted Answer

None we could retrieve, which is the main gap. No Trustpilot aggregate rating was available to us and a BBB search returned no profile. So on product testing you have a genuinely good infrastructure — 32 published certificates from named laboratories with matching lot numbers — and on service, billing, delivery and refunds you have essentially the company's own word. One structural detail worth noticing: the policy links from the storefront are split across two domains, carmensmedicinals.com and carmenshealth.com, with shipping, privacy and terms pages served from the second. That is not sinister in itself — brands commonly operate multiple storefronts on shared infrastructure — but it makes the binding terms harder to pin down, and we would want a single clear set of policies before committing to a subscription. The proportionate response is the usual one: buy a single item rather than the $186.87 bundle, use a card that gives you a chargeback route, keep your order confirmation, and read the refund policy before rather than after. If you intend to subscribe, get the post-introductory price and the cancellation route in writing, since the advertised discount covers only the first three orders.

Question 9

Who should buy this and who should not?

Accepted Answer

Buy if you want plain CBD oil or capsules from a brand that publishes real, lot-matched certificates from named laboratories — which is more than a lot of this category manages, and the single most important thing to check when buying CBD. Start with a smaller item rather than the bundle, buy the higher-strength oil if you already know CBD suits you because it is roughly twice the value per milligram, and match your lot number to a certificate before you take it. Do not buy the FIT THCV oil for cravings or blood sugar. The cravings claim rests on preliminary human evidence, the receptor it acts on has an unhappy regulatory history in weight medicine, the per-serving dose is not stated on the page, and if you are on a GLP-1 you are already paying for appetite suppression that works. Do not buy the THC-containing gummies if you are drug tested, and do not buy them as a long-term habit given the 0.4mg per-container cap arriving on 12 November 2026. Do not treat 'Pain Gummies' as a reason to skip getting chronic pain diagnosed. And if you are having chemotherapy, talk to your oncology team before taking any CBD product, because the CYP450 interaction with cytotoxic drugs is real.

Approach	Evidence	Status
Semaglutide 2.4mg	STEP 1, thousands of participants, randomised, placebo-controlled, 68 weeks: 14.9% vs 2.4%	FDA-approved
Rimonabant (CB1)	Full development programme; licensed in Europe 2006 for obesity	Withdrawn 2008–09 over depression and suicidality
THCV (Carmen's FIT)	Small preliminary studies at 8–16mg/day; an earlier diabetes trial improved glycaemia without weight loss	Supplement; per-serving dose not stated

Carmen's Medicinals Review